MetaVia Inc
MTVA
NASDAQ
Biotechnology
$1.49
USD
+0.03 (+2.05%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $9.62M
Volume 69.2K
Price Target
$20.00 – $20.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $20.00 and a min estimate of $20.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$20.00
Unchanged vs prior
Implied Upside
+1242.3%
Unchanged vs prior
Analyst Covering
1
Unchanged vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Andrew S. Fein | HC Wainwright & Co. | Buy | Reiterated | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
XCUR
Exicure Inc
$1.25
▼ -4.6%
VTGN
Vistagen Therapeutics Inc
$0.2700
▲ +0.5%
LNAI
Lunai Bioworks Inc
$2.22
▼ -0.9%
BIVI
BioVie Inc
$1.40
▼ -10.3%
LSTA
Lisata Therapeutics Inc
$1.09
▼ -3.5%
SNGX
Soligenix Inc
$0.4000
▲ +5.0%
APRE
Aprea Therapeutics Inc
$0.6800
▲ +1.3%
LIMN
Liminatus Pharma Inc
$0.1400
▼ -6.6%
IMNN
Imunon Inc
$1.65
▲ +4.4%